These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 25190187)

  • 1. Strategies to improve drug development for sepsis.
    Fink MP; Warren HS
    Nat Rev Drug Discov; 2014 Oct; 13(10):741-58. PubMed ID: 25190187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins and sepsis.
    Gao F; Linhartova L; Johnston AM; Thickett DR
    Br J Anaesth; 2008 Mar; 100(3):288-98. PubMed ID: 18276651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Agents in Development for Sepsis: Any Reason for Hope?
    Vignon P; Laterre PF; Daix T; François B
    Drugs; 2020 Nov; 80(17):1751-1761. PubMed ID: 32951149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*.
    Opal SM; Dellinger RP; Vincent JL; Masur H; Angus DC
    Crit Care Med; 2014 Jul; 42(7):1714-21. PubMed ID: 24717456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.
    Hagel S; Fiedler S; Hohn A; Brinkmann A; Frey OR; Hoyer H; Schlattmann P; Kiehntopf M; Roberts JA; Pletz MW;
    Trials; 2019 Jun; 20(1):330. PubMed ID: 31171029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why have clinical trials in sepsis failed?
    Marshall JC
    Trends Mol Med; 2014 Apr; 20(4):195-203. PubMed ID: 24581450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapies for sepsis: a review.
    Deans KJ; Haley M; Natanson C; Eichacker PQ; Minneci PC
    J Trauma; 2005 Apr; 58(4):867-74. PubMed ID: 15824673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current evidence for the treatment of sepsis with Xuebijing injection: Bioactive constituents, findings of clinical studies and potential mechanisms.
    Li C; Wang P; Li M; Zheng R; Chen S; Liu S; Feng Z; Yao Y; Shang H
    J Ethnopharmacol; 2021 Jan; 265():113301. PubMed ID: 32860891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroids in sepsis: an updated systematic review and meta-analysis (protocol).
    Rochwerg B; Oczkowski S; Siemieniuk RA; Menon K; Szczeklik W; English S; Agoritsas T; Belley-Cote E; D'Aragon F; Alhazzani W; Duan E; Gossack-Keenan K; Sevransky J; Vandvik P; Venkatesh B; Guyatt G; Annane D
    BMJ Open; 2017 Jun; 7(6):e016847. PubMed ID: 28667229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential therapeutic targets for sepsis in women.
    Weniger M; D'Haese JG; Angele MK; Chaudry IH
    Expert Opin Ther Targets; 2015; 19(11):1531-43. PubMed ID: 26083575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sepsis: a roadmap for future research.
    Cohen J; Vincent JL; Adhikari NK; Machado FR; Angus DC; Calandra T; Jaton K; Giulieri S; Delaloye J; Opal S; Tracey K; van der Poll T; Pelfrene E
    Lancet Infect Dis; 2015 May; 15(5):581-614. PubMed ID: 25932591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis.
    Turgeon AF; Hutton B; Fergusson DA; McIntyre L; Tinmouth AA; Cameron DW; Hébert PC
    Ann Intern Med; 2007 Feb; 146(3):193-203. PubMed ID: 17283351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecules in treatment of sepsis.
    Hu Y; Xie GH; Chen QX; Fang XM
    Curr Drug Targets; 2011 Feb; 12(2):256-62. PubMed ID: 21126227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis.
    Soares MO; Welton NJ; Harrison DA; Peura P; Shankar- Hari M; Harvey SE; Madan JJ; Ades AE; Palmer SJ; Rowan KM
    Health Technol Assess; 2012; 16(7):1-186. PubMed ID: 22361003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sepsis: Current Definition, Pathophysiology, Diagnosis, and Management.
    Taeb AM; Hooper MH; Marik PE
    Nutr Clin Pract; 2017 Jun; 32(3):296-308. PubMed ID: 28537517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trial design for unmet clinical needs: a spotlight on sepsis.
    Vincent JL; Sakr Y
    Expert Rev Clin Pharmacol; 2019 Sep; 12(9):893-900. PubMed ID: 31295413
    [No Abstract]   [Full Text] [Related]  

  • 19. Sepsis and controlled clinical trials: the odyssey continues.
    Bone RC
    Crit Care Med; 1995 Aug; 23(8):1313-5. PubMed ID: 7634799
    [No Abstract]   [Full Text] [Related]  

  • 20. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature.
    Cronin L; Cook DJ; Carlet J; Heyland DK; King D; Lansang MA; Fisher CJ
    Crit Care Med; 1995 Aug; 23(8):1430-9. PubMed ID: 7634816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.